You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: October 12, 2024

METOLAZONE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for metolazone and what is the scope of freedom to operate?

Metolazone is the generic ingredient in four branded drugs marketed by Gd Searle Llc, Alembic, Ani Pharms, Bayshore Pharms Llc, Innogenix, Leading, Mylan, Ne Rx Pharma, Renata, Roxane, Rubicon, Sandoz, Watson Labs, Chartwell Molecular, and I3 Pharms, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for metolazone. Eighteen suppliers are listed for this compound.

Summary for METOLAZONE
Drug Prices for METOLAZONE

See drug prices for METOLAZONE

Drug Sales Revenue Trends for METOLAZONE

See drug sales revenues for METOLAZONE

Recent Clinical Trials for METOLAZONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johannes GrandPhase 4
Stadtspital ZürichPhase 4
Ospedale Regionale di LuganoPhase 4

See all METOLAZONE clinical trials

Pharmacology for METOLAZONE
Drug ClassThiazide-like Diuretic
Physiological EffectIncreased Diuresis
Medical Subject Heading (MeSH) Categories for METOLAZONE
Anatomical Therapeutic Chemical (ATC) Classes for METOLAZONE

US Patents and Regulatory Information for METOLAZONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan METOLAZONE metolazone TABLET;ORAL 076698-001 Dec 23, 2003 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs METOLAZONE metolazone TABLET;ORAL 076891-001 Jul 21, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Gd Searle Llc DIULO metolazone TABLET;ORAL 018535-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.